| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.23 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |